Polymyositis Clinical Trial
Official title:
Prevalence of Inflammatory Myopathies in Alsace
Knowledge of the descriptive epidemiology of MIs is very limited. The main objective of this study is to determine the prevalence of inflammatory myopathies in Alsace at the 1st January 2012 with "capture-recapture" design using several independent sources of case identification.
Inflammatory myopathies (MIs) are a group of muscle diseases with a significant
heterogeneity, clinical, immunological and prognosis.
The old classifications, still currently used, highlight this heterogeneity. Therefore
Troyanov and coll. and Hoogendijk and coll. have each recently proposed a classification
based on clinical and serological - and immuno- histological examination.
The pathogenesis and prognosis of MIs is very different depending on the entity in question.
Knowledge of the descriptive epidemiology of MIs is very limited. In fact no epidemiological
work using criteria consensual classification is actually started.
We propose an epidemiological study of MIs. The main objective of the study is to determine
the prevalence of MIs in Alsace at 1stJanuary 2012 by means of a "capture- recapture" study
using several independent sources of case identification. The secondary objectives of the
study are:
- estimating the geographical distribution of the disease in the Alsace region and / or
Auvergne
- demographic description of patients : age, sex, residence , occupation
- description of the disease: patient age at diagnosis, disease classification , main
clinical manifestations and complications
- Identification of paraneoplastic forms will be for the Alsace region by crossing with
Alsatian cancer registries. These records will be interviewed to identify cases of MIs
associated with cancers.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05833711 -
Study Evaluating Efficacy and Safety of Froniglutide (PF1801) in Patients With Idiopathic Inflammatory Myopathy
|
Phase 2 | |
| Completed |
NCT01906372 -
Acthar in Treatment of Refractory Dermatomyositis and Polymyositis
|
Phase 2 | |
| Completed |
NCT01813617 -
Outcome in Patients With Recent Onset Polymyositis and Dermatomyositis
|
N/A | |
| Completed |
NCT01165008 -
Anakinra in Myositis
|
Phase 2/Phase 3 | |
| Recruiting |
NCT05832034 -
Add-on Intravenous Immunoglobulins in Early Myositis
|
Phase 2 | |
| Recruiting |
NCT05979441 -
A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Active Idiopathic Inflammatory Myopathy
|
Phase 3 | |
| Not yet recruiting |
NCT05027152 -
Muscle Function and Effects of Repetitive Task Training in Patients With Inflammatory Myopaties
|
N/A | |
| Active, not recruiting |
NCT04723303 -
Phase 1 Study of ULSC in Patients With Polymyositis (PM) and Dermatomyositis (DM)
|
Early Phase 1 | |
| Recruiting |
NCT05523167 -
A Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants With Active Idiopathic Inflammatory Myopathy.
|
Phase 2/Phase 3 | |
| Recruiting |
NCT03324152 -
Effects of High-intensity Interval Training (HIIT) in Recent Onset Polymyositis and Dermatomyositis
|
N/A | |
| Completed |
NCT02043548 -
Tocilizumab in the Treatment of Refractory Polymyositis and Dermatomyositis
|
Phase 2 | |
| Completed |
NCT03414086 -
Predictor of Clinical Response to Acthar in Myositis
|
||
| Completed |
NCT04628936 -
Open-label Extension to the Phase 2 Crossover Study (PRESIDIO) Evaluating KZR-616 in Patients With PM and DM.
|
Phase 2 | |
| Completed |
NCT00213629 -
myoARRAY and TcLandscape Analysis for the Diagnosis of Inflammatory Myopathies
|
N/A | |
| Completed |
NCT02971683 -
Trial to Evaluate the Efficacy and Safety of Abatacept in Combination With Standard Therapy Compared to Standard Therapy Alone in Improving Disease Activity in Adults With Active Idiopathic Inflammatory Myopathy
|
Phase 3 | |
| Active, not recruiting |
NCT00651040 -
Combined Treatment of Methotrexate + Glucocorticoids Versus Glucocorticoids Alone in Patients With Polymyositis and Dermatomyositis
|
Phase 3 | |
| Completed |
NCT00138983 -
Prevention of Glucocorticoid-Induced Osteoporosis in Rheumatic Diseases: Alendronate Versus Alfacalcidol.
|
Phase 3 | |
| Completed |
NCT00001331 -
Genetic and Family Studies of Inherited Muscle Diseases
|
N/A | |
| Completed |
NCT00001261 -
Intravenousimmunoglobulin (IVIg) for the Treatment of Inflammatory Myopathies
|
Phase 2 | |
| Completed |
NCT01415219 -
Efficacy of an Individual Rehabilitation Program in Polymyositis and Dermatomyositis
|
Phase 2 |